Next Article in Journal
Predicting Difficult Tracheal Intubation Using Multi-Angle Photographic Analysis with Convolutional Neural Networks and EfficientNet
Previous Article in Journal
Deep Learning Identifies Abnormal Promyelocytes in Peripheral Blood Based on Morphological Analysis
Previous Article in Special Issue
Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786

by
Anna Maria Bednarek
1,*,
Aleksander Jerzy Owczarek
2,
Dominika Dziadosz
3,
Magdalena Olszanecka-Glinianowicz
2 and
Jerzy Tadeusz Chudek
4,5
1
Department of Cardiac Surgery, Upper Silesian Heart Center, 40-635 Katowice, Poland
2
Health Promotion and Obesity Management Unit, Department of Pathophysiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-751 Katowice, Poland
3
First Department of Cardiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-635 Katowice, Poland
4
Department of Internal Medicine and Oncological Chemotherapy, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-029 Katowice, Poland
5
Angiology Outpatient Clinic “Combi-Med”, 42-218 Czestochowa, Poland
*
Author to whom correspondence should be addressed.
Diagnostics 2026, 16(7), 1040; https://doi.org/10.3390/diagnostics16071040
Submission received: 23 March 2026 / Accepted: 23 March 2026 / Published: 30 March 2026
(This article belongs to the Special Issue Recent Advances in Biomarkers for Cardiovascular Disease)
In the original publication [1], the informed consent statement was marked as not applicable. After confirmation with the authors, the correct informed consent statement should be: Informed consent was obtained from all subjects involved in the study.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor, and the original publication has also been updated.

Reference

  1. Bednarek, A.M.; Owczarek, A.J.; Dziadosz, D.; Olszanecka-Glinianowicz, M.; Chudek, J.T. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bednarek, A.M.; Owczarek, A.J.; Dziadosz, D.; Olszanecka-Glinianowicz, M.; Chudek, J.T. Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786. Diagnostics 2026, 16, 1040. https://doi.org/10.3390/diagnostics16071040

AMA Style

Bednarek AM, Owczarek AJ, Dziadosz D, Olszanecka-Glinianowicz M, Chudek JT. Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786. Diagnostics. 2026; 16(7):1040. https://doi.org/10.3390/diagnostics16071040

Chicago/Turabian Style

Bednarek, Anna Maria, Aleksander Jerzy Owczarek, Dominika Dziadosz, Magdalena Olszanecka-Glinianowicz, and Jerzy Tadeusz Chudek. 2026. "Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786" Diagnostics 16, no. 7: 1040. https://doi.org/10.3390/diagnostics16071040

APA Style

Bednarek, A. M., Owczarek, A. J., Dziadosz, D., Olszanecka-Glinianowicz, M., & Chudek, J. T. (2026). Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786. Diagnostics, 16(7), 1040. https://doi.org/10.3390/diagnostics16071040

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop